UK markets close in 7 hours 11 minutes

Aptose Biosciences Inc. (LTI.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.13000.0000 (0.00%)
As of 08:00AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
36,765
36,765
28,088
45,985
29,288
Selling general and administrative
15,542
15,542
14,433
19,324
26,345
Total operating expenses
52,356
52,356
42,602
65,447
55,768
Operating income or loss
-52,356
-52,356
-42,602
-65,447
-55,768
Total other income/expenses net
-2
-2
-9
-1
8
Income before tax
-51,207
-51,207
-41,823
-65,354
-55,238
Income from continuing operations
-51,207
-51,207
-41,823
-65,354
-55,238
Net income
-51,207
-51,207
-41,823
-65,354
-55,238
Net income available to common shareholders
-51,207
-51,207
-41,823
-65,354
-55,238
Basic EPS
-7.72
-
-6.80
-10.95
-10.05
Diluted EPS
-7.72
-
-6.80
-10.95
-10.05
Basic average shares
6,332
-
6,151
5,939
5,456
Diluted average shares
6,332
-
6,151
5,939
5,456